• Barr J N, Wertz G W. Bunyamwera bunyavirus RNA synthesis requires cooperation of 3'-and 5'-terminal sequences[J]. J Virol, 2004, 78(): 1129-1138. doi: 10.1128/JVI.78.3.1129-1138.2004

  • Chai J J, Xiao C E, Liu Y H. Report of Investigation on Hemorrhagic Fever in Bachu County, Xinjiang in 1966 Ⅲ. Investigation an Epidemiology of Hemorrhagic Fever in Bachu[J]. Endemic Disease Bulletin (in chinese), 2004, 19S(): 15-22.

  • Chinikar S, Ghiasi S M, Hewson R. Crimean-Congo hemorrhagic fever in Iran and neighboring countries[J]. J Clin Virol, 2010, 47(): 110-114. doi: 10.1016/j.jcv.2009.10.014

  • Deng F, Wang R R, Fang M G. Proteomics analysis of Helicoverpa armigera single nucleocapsid nucleopolyhedrovirus identified two new occlusion-derived virus-associated proteins, HA44 and HA100[J]. J Virol, 2007, 81(): 9377-9385. doi: 10.1128/JVI.00632-07

  • Deyde V M, Khristova M L, Rollin P E. Crimean-Congo hemorrhagic fever virus genomics and global diversity[J]. J Virol, 2006, 80(): 8834-8842. doi: 10.1128/JVI.00752-06

  • Elevli M, Ozkul A A, Civilibal M. A newly identified Crimean-Congo hemorrhagic fever virus strain in Turkey[J]. Int J Infect Dis, 2010, 14(Suppl (3)): e213-216.

  • Elliott R M. Molecular biology of the Bunyaviridae[J]. J Gen Virol, 1990, 71(): 501-522. doi: 10.1099/0022-1317-71-3-501

  • Ergonul O. Crimean-Congo haemorrhagic fever[J]. Lancet Infect Dis, 2006, 6(): 203-214. doi: 10.1016/S1473-3099(06)70435-2

  • Ergonul O. Treatment of Crimean-Congo hemorrhagic fever[J]. Antiviral Res, 2008, 78(): 125-131. doi: 10.1016/j.antiviral.2007.11.002

  • Flick R. 2007. Chapter 4: Molecular Biology of the Crimean-Congo Hemorrhagic Fever Virus. In: Crimean-Congo Hemorrhagic Fever (O Ergonul, C A Whitehouse ed. ). Springer Netherlands, p 35-44.

  • Frank S A. 2002. Immunology and Evolution of Infectious Disease. Princeton (NJ): Pricenton University Press, p94-108.

  • Fu T M, Guan L, Friedman A. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge[J]. J Immunol, 1999, 162(): 4163-4170.

  • Ghodake R S, Babar R S, Patil S B, et al. 2011. CCHFV-an emerging infectious disease. Pharma science monitor: An international journal of pharmaceutical sciences, 1067-1087.

  • Hewson R, Chamberlain J, Mioulet V. Crimean-Congo haemorrhagic fever virus: sequence analysis of the small RNA segments from a collection of viruses world wide[J]. Virus Res, 2004, 102(): 185-189. doi: 10.1016/j.virusres.2003.12.035

  • King L A, Possee R D. 1992. The baculovirus expression system: A laboratory guide. New York, NY (USA): Chapman & Hall. p158-159.

  • Kunkel M, Lorinczi M, Rijnbrand R. Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein[J]. J Virol, 2001, 75(): 2119-2129. doi: 10.1128/JVI.75.5.2119-2129.2001

  • Lazo L, Gil L, Lopez C. Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus[J]. Arch Virol, 2010, 155(): 1587-1595. doi: 10.1007/s00705-010-0734-9

  • Liu L, Celma C C, Roy P. Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins[J]. Virol J, 2008, 5(): 82-. doi: 10.1186/1743-422X-5-82

  • Liu S J, Leng C H, Lien S P. Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates[J]. Vaccine, 2006, 24(): 3100-3108. doi: 10.1016/j.vaccine.2006.01.058

  • Lopez C, Gil L, Lazo L. In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus[J]. Arch Virol, 2009, 154(): 695-698. doi: 10.1007/s00705-009-0350-8

  • Ma B J, Wang H. The hacker of mount Tianshan— Crimean-Congo hemorrhagic fever virus[J]. Foreign medical Sciences (Section of Virology) (in chinese), 2000, 7(): 8-10.

  • Midilli K, Gargılı A, Ergonul O. Imported Crimean-Congo hemorrhagic fever cases in Istanbul[J]. BMC Infectious Diseases, 2007, 7(): 54-. doi: 10.1186/1471-2334-7-54

  • Ozdarendeli A, Canakoglu N, Berber E. The complete genome analysis of Crimean-Congo hemorrhagic fever virus isolated in Turkey[J]. Virus Res, 2010, 147(): 288-293. doi: 10.1016/j.virusres.2009.11.009

  • Reguera J, Weber F, Cusack S. Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription[J]. PLoS Pathogens, 2010, 6(): 1-14.

  • Saijo M, Qing T, Niikura M. Recombinant nucleoprotein-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus[J]. J Clin Microbiol, 2002, 40(): 1587-1591. doi: 10.1128/JCM.40.5.1587-1591.2002

  • Tang Q. Crimean-Congo hemorrhagic fever virus recently research progress[J]. Chinese J Exp Clin Virol (in chinese), 2006, 20(): 86-89.

  • Wang M L, Tan Y, Yin F F. The F-like protein Ac23 enhances the infectivity of the budded virus of gp64-null Autographa californica multinucleocapsid nucleopolyhedrovirus pseudotyped with baculovirus envelope fusion protein F[J]. J Virol, 2008, 82(): 9800-9804. doi: 10.1128/JVI.00759-08

  • Wang M L, Tuladhar E, Shen S. Specificity of baculovirus P6.9 basic DNA-binding proteins and critical role of the C terminus in virion formation[J]. J Virol, 2010, 84(): 8821-8828. doi: 10.1128/JVI.00072-10

  • Wang R l, Jin N Y, Zhao B. Expression of the Gene Encoding the N Protein of SARS Virus in E.coli and Its Usd in the Immunization of Hourse[J]. Virologica Sinica (in chinese), 2005, 20(): 582-585.

  • Wasmoen T L, Kadakia N P, Unfer R C. Protection of cats from infectious peritonitis by vaccination with a recombinant raccoon poxvirus expressing the nucleocapsid gene of feline infectious peritonitis virus[J]. Adv Exp Med Biol, 1995, 380(): 221-228. doi: 10.1007/978-1-4615-1899-0

  • Wei P F, Luo Y J, Li T X. Serial expression of the truncated fragments of the nucleocapsid protein of CCHFV and identification of the epitope region[J]. Virologica Sinica, 2010, 25(): 45-51. doi: 10.1007/s12250-010-3067-7

  • Whitehouse C A. Crimean-Congo hemorrhagic fever[J]. Antiviral Res, 2004, 64(): 145-160. doi: 10.1016/S0166-3542(04)00163-9

  • Wilson J A, Hart M K. Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein[J]. J Virol, 2001, 75(): 2660-2664. doi: 10.1128/JVI.75.6.2660-2664.2001

  • Xia H, Li P, Yang J. Epidemiological survey of Crimean-Congo hemorrhagic fever virus in Yunnan, China, 2008[J]. Int J Infect Dis, 2011, 15(): e459-463. doi: 10.1016/j.ijid.2011.03.013